Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
Abstract Amphiregulin (AREG) is a ligand of epidermal growth factor receptor and participates in the fibrosis of multiple organs. However, whether AREG can regulate hypertrophic cardiomyopathy is not well known. This research aims to explore the effect of AREG on cardiac hypertrophy, and whether the...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Biology Direct |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13062-022-00334-w |